Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA1 | P00915 | 6/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.48 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27517752 | 0.98 | MIF (0.52) | MIFHSD17B10TSHRTP53TRPA1 | |
| Paraben SCHEMBL6755103 | 0.92 | CA2 (0.59) | MIFHSD17B10TSHRTP53TRPA1 | |
| SCHEMBL6755096 | 0.86 | PRSS1 (0.53) | HSD17B10 | |
| SCHEMBL941258 | 0.84 | P2RY6 (0.50) | MIFHSD17B10CA2CA1P2RY6 | |
| SCHEMBL23481284 | 0.83 | HSD17B10 (0.49) | MIFHSD17B10TRPA1CA2CA1 | |
| SCHEMBL635606 | 0.82 | MIF (0.59) | MIFHSD17B10TRPA1CA2CA1 | |
| SCHEMBL3398682 | 0.81 | KDM4E (0.50) | MIFHSD17B10TRPA1CA2CA1 | |
| SCHEMBL1308638 | 0.81 | NOS3 (0.53) | MIFHSD17B10CA2CA1P2RY6 | |
| SCHEMBL10576522 | 0.81 | P2RY6 (0.52) | MIFHSD17B10TSHRTRPA1CA2 | |
| SCHEMBL3322047 | 0.81 | HSD17B10 (0.47) | MIFHSD17B10TRPA1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115818810-B | Composite polyaluminium chloride water treatment agent and preparation method thereof | 安徽科凌沃特水处理技术有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-117457312-A | Magnetic molecular probe for specifically capturing metabolites from complex sample, and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2024-01-26 | — | — | CN | claimed |
| CN-117342991-A | Sustained-release high-alkaline cement reinforcing agent and preparation method and application thereof | 华新水泥股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-114853650-B | Material for specifically capturing ammonia compounds from complex sample and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-115818810-A | Composite polyaluminium chloride water treatment agent and preparation method thereof | 安徽科凌沃特水处理技术有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-114853650-A | Material for specifically capturing ammonia compound from complex sample and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2022-08-05 | — | — | CN | claimed |
| US-20220233501-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS INC (US) | 2022-07-28 | — | — | US | claimed |
| CN-110681495-B | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2021-08-06 | — | — | CN | claimed |
| WO-2020167748-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS, INC. (US) | 2020-08-20 | — | — | WO | claimed |
| US-20200253926-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS, INC. | 2020-08-13 | — | — | US | claimed |
| CN-110681495-A | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2020-01-14 | — | — | CN | claimed |
| EP-2445345-B1 | BENZAMIDE DERIVATIVES | TRANSLATIONAL GENOMICS RES INST (US) | 2014-08-27 | — | — | EP | claimed |
| US-20120125775-A1 | CHEMICAL MODIFICATION OF PROTEINS FOR THEIR MORE ACCURATE MOLECULAR-WEIGHT DETERMINATION BY ELECTROPHORESIS | DOLNIK VLADISLAV (US) | 2012-05-24 | — | — | US | claimed |
| US-20070190659-A1 | Method for analyzing n-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2007-08-16 | — | — | US | claimed |
| EP-1738177-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | Adduct Analys AB (SE) | 2007-01-03 | — | — | EP | claimed |
| WO-2005101020-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2005-10-27 | — | — | WO | claimed |
| EP-0236646-B1 | ORTHO-ANISAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATIONS | Laboratoires DELAGRANGE, Société Anonyme (FR) | 1990-10-10 | — | — | EP | claimed |
| EP-0236646-A1 | Ortho-anisamides, process for their preparation and their pharmaceutical applications | Laboratoires DELAGRANGE, Société Anonyme (FR) | 1987-09-16 | — | — | EP | claimed |
| EP-4701635-A1 | 1,2,4-TRIAZOLE-3-THIONE INHIBITORS OF TREX2 FOR USE IN THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR ICHTHYOSIS | Universitat De Barcelona (ES) | 2026-03-04 | — | — | EP | disclosed |
| EP-4508038-A1 | COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO | The United States Government as represented by the Department of Veterans Affairs (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-115818810-B | Composite polyaluminium chloride water treatment agent and preparation method thereof | 安徽科凌沃特水处理技术有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024223907-A1 | 1,2,4-TRIAZOLE-3-THIONE INHIBITORS OF TREX2 FOR USE IN THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR ICHTHYOSIS | UNIVERSITAT DE BARCELONA (ES) | 2024-10-31 | — | — | WO | disclosed |
| CN-115557908-B | Triazine derivative containing sulfur connecting bond, and synthesis method and application thereof | 九江学院 | 2024-10-15 | — | — | CN | disclosed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117457312-A | Magnetic molecular probe for specifically capturing metabolites from complex sample, and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2024-01-26 | — | — | CN | disclosed |
| CN-117342991-A | Sustained-release high-alkaline cement reinforcing agent and preparation method and application thereof | 华新水泥股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023201374-A1 | COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) | 2023-10-19 | — | — | WO | disclosed |
| CN-116761484-A | Perovskite film and preparation method and application thereof | 青岛科技大学 | 2023-09-15 | — | — | CN | disclosed |
| CN-113402473-B | Thiotriazole compound, preparation method and application thereof | 四川省医学科学院·四川省人民医院 | 2023-06-23 | — | — | CN | disclosed |
| CN-114853650-B | Material for specifically capturing ammonia compounds from complex sample and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2023-04-28 | — | — | CN | disclosed |
| CN-115818810-A | Composite polyaluminium chloride water treatment agent and preparation method thereof | 安徽科凌沃特水处理技术有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-115557908-A | Triazine derivative containing sulfur connecting bond and synthesis method and application thereof | 九江学院 | 2023-01-03 | — | — | CN | disclosed |
| CN-114853650-A | Material for specifically capturing ammonia compound from complex sample and preparation method and application thereof | 中国医学科学院基础医学研究所 | 2022-08-05 | — | — | CN | disclosed |
| US-20220233501-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS INC (US) | 2022-07-28 | — | — | US | disclosed |
| CN-111849122-B | Resin composition and application thereof | 常熟生益科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| US-20220031661-A1 | SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION | UNIVERSITY OF KANSAS | 2022-02-03 | — | — | US | disclosed |
| CN-113402473-A | Thiotriazole compound, preparation method and application thereof | 四川省医学科学院·四川省人民医院 | 2021-09-17 | — | — | CN | disclosed |
| CN-110681495-B | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-111849122-A | Resin composition and application thereof | 常熟生益科技有限公司 | 2020-10-30 | — | — | CN | disclosed |
| WO-2020167748-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS, INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20200253926-A1 | THERAPEUTIC COMBINATIONS | SUPERSALUS, INC. | 2020-08-13 | — | — | US | disclosed |
| CN-106916101-B | NAMPT/HDAC double-target inhibitor and preparation method thereof | 聚缘（上海）生物科技有限公司 | 2020-05-01 | — | — | CN | disclosed |
| CN-110681495-A | Thiourea compound flotation separation inhibitor and flotation separation method thereof | 北京矿冶科技集团有限公司 | 2020-01-14 | — | — | CN | disclosed |
| US-9486535-B2 | Methods of making and using nanostructures | TYCHON BIOSCIENCE, LLC (US) | 2016-11-08 | — | — | US | disclosed |
| US-9486535-B2 | Methods of making and using nanostructures | TYCHON BIOSCIENCE, LLC (US) | 2016-11-08 | — | — | US | disclosed |
| US-RE46171-E1 | Functional biopolymer modification reagents and uses thereof | SOLULINK, INCORPORATED (US) | 2016-10-04 | — | — | US | disclosed |
| US-RE46171-E1 | Functional biopolymer modification reagents and uses thereof | SOLULINK, INCORPORATED (US) | 2016-10-04 | — | — | US | disclosed |
| EP-2492262-B1 | FUSED HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | NISSAN CHEMICAL IND LTD (JP) | 2016-04-20 | — | — | EP | disclosed |
| US-9102602-B2 | Method for producing isothiocyanate compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-9102602-B2 | Method for producing isothiocyanate compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-9102602-B2 | Method for producing isothiocyanate compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-08-11 | — | — | US | disclosed |
| US-8889732-B2 | Fused heterocyclic compounds and thrombopoietin receptor activators | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-20140249191-A1 | Compositions for Controlling Vascularization in Ophthalmological and Dermatological Diseases | AVIENNE PHARMACEUTICALS GMBH (AT) | 2014-09-04 | — | — | US | disclosed |
| EP-1660519-B1 | Conjugates comprising 2-[18F]fluoro-2-deoxy-D-glucose and a peptide molecule | IMMUNOMEDICS INC (US) | 2014-05-14 | — | — | EP | disclosed |
| CN-101965331-B | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL IND LTD | 2014-04-16 | — | — | CN | disclosed |
| US-8614330-B2 | Substituted benz-azoles and methods of their use as inhibitors of RAF kinase | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2013-12-24 | — | — | US | disclosed |
| EP-2647623-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2013-10-09 | — | — | EP | disclosed |
| EP-2647623-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130245305-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130245305-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130245305-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-8497371-B2 | Pipemidic acid derivative autotaxin inhibitors | UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) | 2013-07-30 | — | — | US | disclosed |
| US-8449880-B2 | Chemical modification of proteins for their more accurate molecular-weight determination by electrophoresis | DOLNIK VLADISLAV (US) | 2013-05-28 | — | — | US | disclosed |
| US-8367857-B2 | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| EP-2240175-B1 | COMPOUNDS WITH MDR1-INVERSE ACTIVITY | US GOV HEALTH & HUMAN SERV (US) | 2013-01-02 | — | — | EP | disclosed |
| US-20120288501-A1 | SUBSTITUTED BENZAZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE | NOVARTIS VACCINES AND DIAGNOSTICS, INC. FORMERLY KNOWN AS CHIRON CORPORATION (US) | 2012-11-15 | — | — | US | disclosed |
| US-8299108-B2 | for treatment of hematological/hormone-dependent cancer | NOVARTIS AG (CH) | 2012-10-30 | — | — | US | disclosed |
| EP-2492262-A1 | FUSED HETEROCYCLIC COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR | Nissan Chemical Industries, Ltd. (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120209005-A1 | FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120125775-A1 | CHEMICAL MODIFICATION OF PROTEINS FOR THEIR MORE ACCURATE MOLECULAR-WEIGHT DETERMINATION BY ELECTROPHORESIS | DOLNIK VLADISLAV (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120100592-A1 | PIPEMIDIC ACID DERIVATIVE AUTOTAXIN INHIBITORS | THE UNIVERSITY OF MEMPHIS | 2012-04-26 | — | — | US | disclosed |
| WO-2012033601-A1 | THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2012-03-15 | — | — | WO | disclosed |
| US-8053453-B2 | Pyrazolone compounds and thrombopoietin receptor activator | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-11-08 | — | — | US | disclosed |
| WO-2011053597-A1 | PIPEMIDIC ACID DERIVATIVE AUTOTAXIN INHIBITORS | THE UNIVERSITY OF MEMPHIS RESEARCH FOUNDATION (US) | 2011-05-05 | — | — | WO | disclosed |
| CN-101965331-A | Method for producing isothiocyanate compound having carboxyl group | NISSAN CHEMICAL IND LTD | 2011-02-02 | — | — | CN | disclosed |
| US-20100316655-A1 | COMPOUNDS WITH MDR1-INVERSE ACTIVITY | INSTITUTE OF ENZYMOLOGY, BIOLOGICAL RESEARCH CENTER, HUNGARIAN ACADEMY OF SCIENCES (HU) | 2010-12-16 | — | — | US | disclosed |
| US-20100312000-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | NISSAN CHEMICAL INDUSTRIES LIMITED (JP) | 2010-12-09 | — | — | US | disclosed |
| EP-2248800-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | Nissan Chemical Industries, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-2240175-A2 | COMPOUNDS WITH MDR1-INVERSE ACTIVITY | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) | 2010-10-20 | — | — | EP | disclosed |
| US-20100196368-A1 | SUBSTITUTED BENZ-AZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2010-08-05 | — | — | US | disclosed |
| US-7732628-B2 | Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis | SOLULINK INCORPORATED (US) | 2010-06-08 | — | — | US | disclosed |
| US-7732628-B2 | Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis | SOLULINK INCORPORATED (US) | 2010-06-08 | — | — | US | disclosed |
| US-7728010-B2 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-7718437-B2 | Method for analyzing N-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2010-05-18 | — | — | US | disclosed |
| US-7662977-B2 | PI-3 kinase inhibitor prodrugs | SEMAFORE PHARMACEUTICALS, INC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-7652047-B2 | Phenylamino isothiazole carboxamidines as MEK inhibitors | ARDEA BIOSCIENCES, INC. (US) | 2010-01-26 | — | — | US | disclosed |
| EP-1499311-B1 | SUBSTITUTED BENZAZOLES AND USE THEREOF AS RAF KINASE INHIBITORS | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2009-11-04 | — | — | EP | disclosed |
| WO-2009102433-A2 | COMPOUNDS WITH MDR1-INVERSE ACTIVITY | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-08-20 | — | — | WO | disclosed |
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | disclosed |
| US-7566549-B2 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2009-07-28 | — | — | US | disclosed |
| CN-100515419-C | Substituted benzazoles and its application as inhibitors of Raf kinase | CHIRON CORP (US) | 2009-07-22 | — | — | CN | disclosed |
| EP-1738177-B1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2009-02-11 | — | — | EP | disclosed |
| CN-101352451-A | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA PTY LTD (AU) | 2009-01-28 | — | — | CN | disclosed |
| US-20090011975-A1 | TARGETED BONE MARROW PROTECTION AGENTS | SEMAFORE PHARMACEUTICALS INC. (US) | 2009-01-08 | — | — | US | disclosed |
| US-20080306063-A1 | PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS | ARDEA BIOSCIENCES, INC. (US) | 2008-12-11 | — | — | US | disclosed |
| US-7429667-B2 | Phenylamino isothiazole carboxamidines as MEK inhibitors | ARDEA BIOSCIENCES, INC. (US) | 2008-09-30 | — | — | US | disclosed |
| US-20080188423-A1 | PI-3 KINASE INHIBITOR PRODRUGS | SIGNALRX PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | disclosed |
| US-7396828-B2 | PI-3 kinase inhibitor prodrugs | SEMAFORE PHARMACEUTICALS, INC. (US) | 2008-07-08 | — | — | US | disclosed |
| WO-2008061029-A1 | ARYL SULFONAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-05-22 | — | — | WO | disclosed |
| US-20070299039-A1 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | CHIRON CORPORATION (US) | 2007-12-27 | — | — | US | disclosed |
| EP-1113806-B1 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | STARPHARMA PTY LTD (AU) | 2007-09-05 | — | — | EP | disclosed |
| US-20070190659-A1 | Method for analyzing n-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2007-08-16 | — | — | US | disclosed |
| US-20070122859-A1 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | GHOSHAL MITALI | 2007-05-31 | — | — | US | disclosed |
| CN-1913884-A | Substituted benzazoles and methods of their use as inhibitors of RAF kinase | CHIRON CORP (US) | 2007-02-14 | — | — | CN | disclosed |
| EP-1738177-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | Adduct Analys AB (SE) | 2007-01-03 | — | — | EP | disclosed |
| US-7157560-B2 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2007-01-02 | — | — | US | disclosed |
| WO-2006133417-A1 | PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS | VALEANT PHARMACEUTICALS INTERNATIONAL (US) | 2006-12-14 | — | — | WO | disclosed |
| US-7144989-B2 | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2006-12-05 | — | — | US | disclosed |
| US-7102024-B1 | Functional biopolymer modification reagents and uses thereof | AUDAX PRIVATE DEBT LLC, AS AGENT | 2006-09-05 | — | — | US | disclosed |
| US-20060194802-A1 | Phenylamino isothiazole carboxamidines as MEK inhibitors | ARDEA BIOSCIENCES, INC. | 2006-08-31 | — | — | US | disclosed |
| US-7084112-B2 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2006-08-01 | — | — | US | disclosed |
| EP-1675584-A1 | SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF RAF KINASE | CHIRON CORPORATION (US) | 2006-07-05 | — | — | EP | disclosed |
| US-7071216-B2 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | CHIRON CORPORATION (US) | 2006-07-04 | — | — | US | disclosed |
| EP-0927217-B1 | ANGIOGENIC INHIBITORY COMPOUNDS | STARPHARMA PTY LTD (AU) | 2006-05-03 | — | — | EP | disclosed |
| US-20060069140-A1 | Pyrazolone compounds and thrombopoietin receptor activator | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2006-03-30 | — | — | US | disclosed |
| EP-1615639-A2 | TARGETED BONE MARROW PROTECTION AGENTS | Semafore Pharmaceuticals, Inc. (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1611119-A1 | PI-3 KINASE INHIBITOR PRODRUGS | Semafore Pharmaceuticals, Inc. (US) | 2006-01-04 | — | — | EP | disclosed |
| US-6962954-B2 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2005-11-08 | — | — | US | disclosed |
| WO-2005101020-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2005-10-27 | — | — | WO | disclosed |
| US-6949537-B2 | PI-3 kinase inhibitor prodrugs | SEMAFORE PHARMACEUTICALS, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050203289-A1 | Functional biopolymer modification reagents and uses thereof | AUDAX PRIVATE DEBT LLC, AS AGENT | 2005-09-15 | — | — | US | disclosed |
| US-20050203173-A1 | PI-3 kinase inhibitor prodrugs | SIGNALRX PHARMACEUTICALS, INC. | 2005-09-15 | — | — | US | disclosed |
| CN-1655779-A | substituted indoles and their use as Raf kinase inhibitors | CHIRON CORP (US) | 2005-08-17 | — | — | CN | disclosed |
| US-20050159339-A1 | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. | 2005-07-21 | — | — | US | disclosed |
| CN-1638770-A | Composition and potentiating method | NEW PHARMA RES SWEDEN AB (SE) | 2005-07-13 | — | — | CN | disclosed |
| EP-1549618-A1 | PYRAZOLONE COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS | Nissan Chemical Industries, Ltd. (JP) | 2005-07-06 | — | — | EP | disclosed |
| WO-2005032548-A1 | SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF RAF KINASE | CHIRON CORPORATION (US) | 2005-04-14 | — | — | WO | disclosed |
| US-6858739-B2 | Indole and benzimidazole 15-lipoxygenase inhibitors | WARNER-LAMBERT COMPANY (US) | 2005-02-22 | — | — | US | disclosed |
| EP-1499311-A1 | SUBSTITUTED BENZAZOLES AND USE THEREOF AS RAF KINASE INHIBITORS | Chiron Corporation (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20040242631-A1 | PI-3 kinase inhibitor prodrugs | SIGNALRX PHARMACEUTICALS, INC. | 2004-12-02 | — | — | US | disclosed |
| EP-1042276-B1 | THIOUREA COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER LAMBERT CO (US) | 2004-11-17 | — | — | EP | disclosed |
| WO-2004089925-A1 | PI-3 KINASE INHIBITOR PRODRUGS | SEMAFORE PHARMACEUTICALS, INC. (US) | 2004-10-21 | — | — | WO | disclosed |
| WO-2004089356-A2 | TARGETED BONE MARROW PROTECTION AGENTS | SEMAFORE PHARMACEUTICALS INC. (US) | 2004-10-21 | — | — | WO | disclosed |
| US-20040198783-A1 | Targeted bone marrow protection agents | SEMAFORE PHARMACEUTICALS INC. | 2004-10-07 | — | — | US | disclosed |
| US-6794496-B2 | 2-OXO-DERIVATIVES OF LSD; HAPTEN DERIVATIVES USED TO PREPARE ANTIGENS, ANTIBODIES AND REAGENTS FOR USE IN IMMUNOASSAYS. | ROCHE DIAGNOSTICS CORPORATION | 2004-09-21 | — | — | US | disclosed |
| CN-1161128-C | Angiogenic inhibitory compounds | О | 2004-08-11 | — | — | CN | disclosed |
| US-20040147736-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. | 2004-07-29 | — | — | US | disclosed |
| US-20040127697-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2004-07-01 | — | — | US | disclosed |
| US-20040122237-A1 | Substituted benzazoles and methods of their use as inhibitors of Raf kinase | NOVARTIS AG (CH) | 2004-06-24 | — | — | US | disclosed |
| EP-1113805-A4 | INHIBITION OF TOXIC MATERIALS OR SUBSTANCES USING DENDRIMERS | STARPHARMA LTD (AU) | 2004-05-19 | — | — | EP | disclosed |
| US-6737524-B2 | ARYL ISOTHIOCYANATE DERIVATIVES; ATTACHING TO BIOMOLECULES SUCH AS PROTEINS OR PEPTIDES; ENHANCING IN VIVO CIRCULATION HALFLIFE | Smith, Paul K. | 2004-05-18 | — | — | US | disclosed |
| US-20040087626-A1 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | NOVARTIS AG (CH) | 2004-05-06 | — | — | US | disclosed |
| WO-2004033433-A1 | PYRAZOLONE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATOR | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2004-04-22 | — | — | WO | disclosed |
| US-6720345-B1 | NON PEPTIDES; TREATMENT OF THROMBOCYTOPENIA AND OTHER CONDITIONS WITH DEPRESSED PLATELET FORMATION; PROMOTERS OF THROMBOPOIESIS AND MEGAKARYOCYTOPOIESIS; BLOOD GROWTH FACTOR AGONIST ABLE TO ACCELERATE PLATELET REGENERATION. | SMITHKLINE BEECHAM CORPORATION | 2004-04-13 | — | — | US | disclosed |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | CONNOR DAVID THOMAS (US) | 2004-02-26 | — | — | US | disclosed |
| EP-0816364-B1 | Reagents for lysergic acid diethylamide immunoassay | HOFFMANN LA ROCHE (CH) | 2004-01-02 | — | — | EP | disclosed |
| WO-2003082272-A1 | SUBSTITUTED BENZAZOLES AND USE THEREOF AS RAF KINASE INHIBITORS | CHIRON CORPORATION (US) | 2003-10-09 | — | — | WO | disclosed |
| US-20030187248-A1 | Activated polyethylene glycol compounds | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2003-10-02 | — | — | US | disclosed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | disclosed |
| EP-1113806-A4 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | STARPHARMA LTD (AU) | 2003-06-25 | — | — | EP | disclosed |
| EP-0927217-A4 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RES INST LTD (AU) | 2003-04-23 | — | — | EP | disclosed |
| EP-1294686-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2003-03-26 | — | — | EP | disclosed |
| US-6528528-B2 | Inhibitors of 15-lipoxygenase, inhibiting chemotaxis of monocytes | WARNER-LAMBERT COMPANY | 2003-03-04 | — | — | US | disclosed |
| US-20030013131-A1 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2003-01-16 | — | — | US | disclosed |
| US-6476199-B1 | Reagents for lysergic acid diethylamide immunoassay | ROCHE DIAGNOSTICS CORPORATION | 2002-11-05 | — | — | US | disclosed |
| US-6464971-B1 | ANIONIC-CONTAINING MOIETY IS A NEURAMINIC- OR SIALIC ACID-CONTAINING. MOIETY, IT IS MODIFIED IN THE 4-POSITION BY SUBSTITUTION WITH AN AMINO, AMIDO, CYANO, AZIDO OR GUANIDO GROUP, OR IS UNSATURATED. | STARPHARMA LIMITED (AU) | 2002-10-15 | — | — | US | disclosed |
| EP-1228051-A1 | SEMICARBAZONE DERIVATIVES AND THEIR USE AS THROMBOPOIETIN MIMETICS | SmithKline Beecham Corporation (US) | 2002-08-07 | — | — | EP | disclosed |
| US-6426067-B1 | CARDIOVASCULAR DISORDERS; ANTITUMOR AGENTS | BIOMOLECULAR RESEARCH INSTITUTE, LTD. (AU) | 2002-07-30 | — | — | US | disclosed |
| WO-2002010431-A2 | FUNCTIONAL BIOPOLYMER MODIFICATION REAGENTS AND USES THEREOF | SCHWARTZ DAVID A (US) | 2002-02-07 | — | — | WO | disclosed |
| WO-2001096299-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-12-20 | — | — | WO | disclosed |
| US-20010044118-A1 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2001-11-22 | — | — | US | disclosed |
| CN-1323214-A | Antimicrobial or antiparasitic compositions of anionic or cationic dendrimers | STARPHARMA LTD (AU) | 2001-11-21 | — | — | CN | disclosed |
| CN-1323215-A | Inhibition of toxic materials or substances using dendrimers | STARPHARMA LTD (AU) | 2001-11-21 | — | — | CN | disclosed |
| EP-1148339-A2 | Immunoassay for LSD and 2-Oxo-3-Hydroxy-LSD | Roche Diagnostics Corporation (US) | 2001-10-24 | — | — | EP | disclosed |
| US-20010031874-A1 | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis | CONNOR DAVID THOMAS (US) | 2001-10-18 | — | — | US | disclosed |
| US-6268387-B1 | INHIBITORS OF THE ENZYME 15-LIPOXYGENASE AND ARE INHIBITORS OF MONOCYTE CHEMOTAXIS. | WARNER-LAMBERT COMPANY | 2001-07-31 | — | — | US | disclosed |
| EP-1113805-A1 | INHIBITION OF TOXIC MATERIALS OR SUBSTANCES USING DENDRIMERS | Starpharma Limited (AU) | 2001-07-11 | — | — | EP | disclosed |
| EP-1113806-A1 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | Starpharma Limited (AU) | 2001-07-11 | — | — | EP | disclosed |
| WO-2001034585-A1 | SEMICARBAZONE DERIVATIVES AND THEIR USE AS THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-05-17 | — | — | WO | disclosed |
| US-6217845-B1 | IMAGING; THERAPY | ANORMED, INC. (CA) | 2001-04-17 | — | — | US | disclosed |
| EP-1042276-A1 | THIOUREA COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY LLC (US) | 2000-10-11 | — | — | EP | disclosed |
| US-6063908-A | STABLE HAPTEN DERIVATIVES THAT ARE USEFUL FOR THE PREPARATION OF ANTIGENS, ANTIBODIES AND REAGENTS USED IN DETECTION OF DRUG ABUSE | ROCHE DIAGNOSTICS CORPORATION (US) | 2000-05-16 | — | — | US | disclosed |
| WO-2000015240-A1 | ANIONIC OR CATIONIC DENDRIMER ANTIMICROBIAL OR ANTIPARASITIC COMPOSITIONS | STARPHARMA LIMITED (AU) | 2000-03-23 | — | — | WO | disclosed |
| WO-2000015239-A1 | INHIBITION OF TOXIC MATERIALS OR SUBSTANCES USING DENDRIMERS | STARPHARMA LIMITED (AU) | 2000-03-23 | — | — | WO | disclosed |
| CN-1225654-A | Angiogenic inhibitory compounds | BIOMOLECULAR RES INST LTD (AU) | 1999-08-11 | — | — | CN | disclosed |
| EP-0927217-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1999-07-07 | — | — | EP | disclosed |
| WO-1999032433-A1 | THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |
| EP-0664825-B1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | SECR DEFENCE BRIT (GB) | 1999-03-31 | — | — | EP | disclosed |
| US-5753520-A | BIOCHEMICAL CONJUGATED WITH A HYDRAZINE OR A HYDRAZONE COMPOUND AS DRUG DELIVERY; HIGH BIOLOGICAL SPECIFICITY; MEDICINE FOR IMAGING, THERAPY, RADIOACTIVE TAGGING | JOHNSON MATTHEY INC. (US) | 1998-05-19 | — | — | US | disclosed |
| WO-1998003573-A1 | ANGIOGENIC INHIBITORY COMPOUNDS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1998-01-29 | — | — | WO | disclosed |
| EP-0816364-A1 | Reagents for lysergic acid diethylamide immunoassay | F. HOFFMANN-LA ROCHE AG (CH) | 1998-01-07 | — | — | EP | disclosed |
| US-5578242-A | LIQUID CRYSTALS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF DEFENCE RESEARCH AGENCY (GB) | 1996-11-26 | — | — | US | disclosed |
| EP-0384769-B1 | Protein labelling | JOHNSON MATTHEY PLC (GB) | 1996-04-24 | — | — | EP | disclosed |
| EP-0664825-A1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND (GB) | 1995-08-02 | — | — | EP | disclosed |
| US-5420285-A | Imaging for medicine | JOHNSON MATTHEY, INC. (US) | 1995-05-30 | — | — | US | disclosed |
| US-5393883-A | Ribonucleotide reductase inhibitors | BURROUGHS WELLCOME CO. (US) | 1995-02-28 | — | — | US | disclosed |
| WO-1994009085-A1 | THIO-ESTER COMPOUNDS AND MIXTURES AND DEVICES CONTAINING SUCH COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND OF THE DEFENCE RESEARCH AGENCY (GB) | 1994-04-28 | — | — | WO | disclosed |
| US-5206370-A | Certain pyridyl hydrazines and hydrazides useful for protein labeling | JOHNSON MATTHEY, INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-5175165-A | Acyclovir and a thiocarbonohydrazone ribonucleotide reductase inhibitor for treatment of herpes virus | BURROUGHS WELLCOME CO. (US) | 1992-12-29 | — | — | US | disclosed |
| EP-0349243-B1 | ANTIVIRAL COMBINATIONS AND COMPOUNDS THEREFOR | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-04-01 | — | — | EP | disclosed |
| EP-0220899-B1 | BIFUNCTIONAL LINKER | Immunomedics, Inc. (US) | 1992-03-11 | — | — | EP | disclosed |
| EP-0384769-A2 | Protein labelling | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1990-08-29 | — | — | EP | disclosed |
| US-4914117-A | ANTIDEPRESSANTS, CENTRAL NERVOUS SYSTEM ACTIVATORS; DOPAMINE ANTAGONISTS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLE DE L'ILE-D-FRANCE (FR) | 1990-04-03 | — | — | US | disclosed |
| EP-0349243-A2 | Antiviral combinations and compounds therefor | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-01-03 | — | — | EP | disclosed |
| EP-0117511-B1 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1989-09-20 | — | — | EP | disclosed |
| US-4835172-A | Novel benzamides, intermediates and process for the preparation and therapeutic use thereof | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1989-05-30 | — | — | US | disclosed |
| US-4824659-A | LINKED TO POLY(AMIDE,UREA,THIOUREA); BORON CAGE COMPOUNDS; RADIOTHERAPY OF TUMORS | IMMUNOMEDICS, INC. (US) | 1989-04-25 | — | — | US | disclosed |
| US-4680338-A | Bifunctional linker | IMMUNOMEDICS, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0220899-A1 | Bifunctional linker | Immunomedics, Inc. (US) | 1987-05-06 | — | — | EP | disclosed |
| US-4628024-A | RELEASING A FOGGING AGENT; CONTRAST; STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1986-12-09 | — | — | US | disclosed |
| EP-0117511-A2 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-05 | — | — | EP | disclosed |
| EP-0117511-A2 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (27 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122237-A1 | Substituted benzazoles and methods of their use as inhibitors of Raf kinase | BRAF, RAF1, ARAF | MIF 3961/4885HSD17B10 2741/4885TSHR 3584/4885 |
| US-20030187248-A1 | Activated polyethylene glycol compounds | ADH1C, PIGO, AADAC | MIF 980/4885HSD17B10 1780/4885TSHR 2255/4885 |
| US-20090011975-A1 | TARGETED BONE MARROW PROTECTION AGENTS | APAF1, BST2, MCL1 | MIF 57/4885HSD17B10 4392/4885TSHR 4135/4885 |
| US-20040087626-A1 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | BRAF, RAF1, ARAF | MIF 3921/4885HSD17B10 2353/4885TSHR 3487/4885 |
| US-20050203289-A1 | Functional biopolymer modification reagents and uses thereof | OGG1, OGA, HMOX2 | MIF 3934/4885HSD17B10 1839/4885TSHR 2148/4885 |
| US-20120209005-A1 | FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | MPL, TEK, THPO | MIF 1456/4885HSD17B10 4111/4885TSHR 53/4885 |
| US-20040198783-A1 | Targeted bone marrow protection agents | APAF1, BST2, MCL1 | MIF 57/4885HSD17B10 4392/4885TSHR 4135/4885 |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | ALOX15, ALOX5, ALOX12 | MIF 1133/4885HSD17B10 100/4885TSHR 2040/4885 |
| US-20010044118-A1 | Immunoassay for LSD and 2-oxo-3-hydroxy-LSD | HNMT, HRH3, HRH4 | MIF 771/4885HSD17B10 1739/4885TSHR 2601/4885 |
| US-20080306063-A1 | PHENYLAMINO ISOTHIAZOLE CARBOXAMIDINES AS MEK INHIBITORS | BRAF, MAP4K2, MAP3K4 | MIF 701/4885HSD17B10 4101/4885TSHR 2919/4885 |
| US-20010031874-A1 | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis | TPMT, CTH, CBS | MIF 504/4885HSD17B10 2178/4885TSHR 901/4885 |
| US-20120288501-A1 | SUBSTITUTED BENZAZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE | BRAF, RAF1, ARAF | MIF 3961/4885HSD17B10 2741/4885TSHR 3584/4885 |
| US-20120100592-A1 | PIPEMIDIC ACID DERIVATIVE AUTOTAXIN INHIBITORS | ENPP2, PLA2G6, PLA2G10 | MIF 2324/4885HSD17B10 2224/4885TSHR 3334/4885 |
| US-20100196368-A1 | SUBSTITUTED BENZ-AZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE | BRAF, RAF1, ARAF | MIF 3921/4885HSD17B10 2353/4885TSHR 3487/4885 |
| US-20100312000-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND HAVING CARBOXYL GROUP | CBS, CTH, TST | MIF 4284/4885HSD17B10 1193/4885TSHR 2373/4885 |
| US-20060194802-A1 | Phenylamino isothiazole carboxamidines as MEK inhibitors | BRAF, MAP4K2, MAP3K4 | MIF 701/4885HSD17B10 4101/4885TSHR 2919/4885 |
| US-20140249191-A1 | Compositions for Controlling Vascularization in Ophthalmological and Dermatological Diseases | FLT1, KDR, FLT4 | MIF 1619/4885HSD17B10 277/4885TSHR 4075/4885 |
| US-20070299039-A1 | Substituted benz-azoles and methods of their use as inhibitors of Raf kinase | BRAF, RAF1, ARAF | MIF 3921/4885HSD17B10 2353/4885TSHR 3487/4885 |
| US-20050203173-A1 | PI-3 kinase inhibitor prodrugs | PI4KA, PI4KB, PI4K2B | MIF 1708/4885HSD17B10 3277/4885TSHR 3974/4885 |
| US-20080188423-A1 | PI-3 KINASE INHIBITOR PRODRUGS | PI4KA, PI4KB, PI4K2B | MIF 1708/4885HSD17B10 3277/4885TSHR 3974/4885 |
| US-20040242631-A1 | PI-3 kinase inhibitor prodrugs | PI4KA, PI4KB, PI4K2B | MIF 1708/4885HSD17B10 3277/4885TSHR 3974/4885 |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | FUT6, B3GNT2, SIGLEC7 | MIF 680/4885HSD17B10 4464/4885TSHR 2560/4885 |
| US-20040127697-A1 | Activated polyethylene glycol compounds | ADH1C, PIGO, AADAC | MIF 980/4885HSD17B10 1780/4885TSHR 2255/4885 |
| US-20100316655-A1 | COMPOUNDS WITH MDR1-INVERSE ACTIVITY | ABCC1, ABCB1, ABCC2 | MIF 482/4885HSD17B10 2666/4885TSHR 4378/4885 |
| US-20220031661-A1 | SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION | BLVRB, TFPI, ETFB | MIF 2072/4885HSD17B10 553/4885TSHR 1599/4885 |
| US-20060069140-A1 | Pyrazolone compounds and thrombopoietin receptor activator | MPL, PDGFRA, THPO | MIF 2149/4885HSD17B10 2907/4885TSHR 174/4885 |
| US-20130245305-A1 | METHOD FOR PRODUCING ISOTHIOCYANATE COMPOUND | TST, CTH, ICMT | MIF 2087/4885HSD17B10 2778/4885TSHR 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.